Results 21 to 30 of about 2,984,423 (243)

Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity

Frontiers in Cellular and Infection Microbiology, 2020
The design and development of new pharmaceutical formulations for the existing anti-leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug discovery. Herein hybrid solid lipid nanoparticles (SLN) have been engineered
Shabi Parvez, Ganesh Yadagiri, Archana Karole, Om Prakash Singh, Anurag Verma, Anurag Verma, Shyam Sundar, Shyam Lal Mudavath   +7 more
doaj   +1 more source

Development and optimisation of novel oral formulation of an opioid analgesic using central composite design

Cogent Medicine, 2017
Introduction of matrix type sustained release systems were a breakthrough for novel oral drug delivery systems. Present research focuses on the development and evaluation of Fentanyl citrate sustained release formulations.
Meenal M. Rane, Amrita Bajaj
doaj   +1 more source

Gastroretentive microparticles for drug delivery applications [PDF]

, 2011
Many strategies have been proposed to explore the possibility of exploiting gastroretention for drug delivery. Such systems would be useful for local delivery, for drugs that are poorly soluble at higher pH or primarily absorbed from the proximal small ...
Conway, Barbara R, Barbara R. Conway, Adeola Adebisi, Adebisi, Adeola, Conway, Barbara R., Adebisi, Adeola O.   +5 more
core   +1 more source

Unilateral dental rehabilitation with zygomatic implants after tumor resection surgery: a case series

Journal of Oral Medicine and Oral Surgery
While the placement of zygomatic implants (ZI) has been described in cases of tumor resection in the posterior maxillary regions, few studies describe unilateral fixed prosthetic rehabilitations.
Sockalingum Pierre, Lauwers Ludovic, Nicot Romain, Raoul Gwenaël   +3 more
doaj   +1 more source

Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

Nanomaterials, 2018
Lipid-based drugs are emerging as an interesting class of novel anticancer drugs with the potential to target specific cancer cell metabolic pathways linked to their proliferation and invasiveness.
Gabriela Garrastazu Pereira, Tristan Rawling, Michele Pozzoli, Curtis Pazderka, Yongjuan Chen, Colin R. Dunstan, Michael Murray, Fabio Sonvico   +7 more
doaj   +1 more source

The fourth controlled release society workshop on oral peptide administration

Frontiers in Drug Delivery
The Controlled Release Society (CRS, www.controlledrelease.org) held its fourth iteration of research and development in oral peptide administration on 14 July 2025 in Philadelphia (United States), entitled “Recent advances in oral peptide delivery: from
David J. Brayden, Stephen T. Buckley, Andrew L. Lewis   +2 more
doaj   +1 more source

Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment

International Journal of Nanomedicine, 2022
Hazem Choukaife,1 Salma Seyam,1 Batoul Alallam,2 Abd Almonem Doolaanea,3 Mulham Alfatama1 1Faculty of Pharmacy, Universiti Sultan Zainal Abidin, Besut Campus, Terengganu, 22200, Malaysia; 2Advanced Medical and Dental Institute, Universiti Sains Malaysia,
Choukaife H, Seyam S, Alallam B, Doolaanea AA, Alfatama M   +4 more
doaj  

Pain levels and histological severity in a rat model of chemically-induced temporomandibular joint osteoarthritis

BMC Oral Health
Background This study evaluated the correlation between the degree of osteoarthritis (OA), represented by the Mankin scale score, and pain levels measured by the head withdrawal threshold (HWT) in a chemically-induced rat model of temporomandibular joint
Florent Barry, Feng Chai, Romain Nicot
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Pre-implant surgery complexity for achieving implant-supported prosthetic rehabilitation in oligodontia patients: a retrospective study

BMC Oral Health
Introduction Oligodontia is a rare dental developmental pathology that requires prolonged, complex and multidisciplinary treatment. Although bone augmentation is frequently required during a complete implant treatment of oligodontia.
Ludovic Lauwers, Gwénaël Raoul, Romain Nicot   +2 more
doaj   +1 more source